Eindhoven, Netherlands

Baudouin Denis De Senneville



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Brachytherapy: The Contributions of Baudouin Denis de Senneville

Introduction

Baudouin Denis de Senneville, an inventive mind based in Eindhoven, NL, has made significant strides in the field of medical technology. With a focus on improving brachytherapy procedures, he has developed a novel method that enhances treatment efficacy and patient safety. His work has the potential to shape the future of cancer treatment through targeted therapies.

Latest Patents

Baudouin Denis de Senneville holds a patent for a “Device and method for assisting in a brachytherapy procedure.” This innovative delivery assistance device optimizes treatment plans by considering each stage of the procedure already performed. It enables the adaptation of sequences and dosing adjustments following each needle insertion. By prioritizing steps with a higher risk of error, his invention aims to minimize complications and enhance treatment accuracy.

Career Highlights

Denis de Senneville is currently employed at Koninklijke Philips Corporation N.V., a company known for its commitment to health technology and innovation. His role focuses on advancing solutions that address pressing healthcare challenges, particularly in oncology. Through his work at Philips, he collaborates with a talented team to push the boundaries of medical technology.

Collaborations

Throughout his career, Baudouin has worked alongside notable colleagues, including Maxence Borot de Battisti and Guillaume Leopold Theodorus Frederik Hautvast. Together, they form a multidisciplinary team dedicated to developing cutting-edge solutions aimed at improving patient outcomes in brachytherapy and related procedures.

Conclusion

Baudouin Denis de Senneville is a significant contributor to the field of medical innovation, particularly in enhancing brachytherapy procedures. His patented technology represents a meaningful advancement that could lead to more effective and safer treatment options for patients. As he continues his work at Koninklijke Philips Corporation N.V., his endeavors will undoubtedly influence the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…